TKT and prostate cancer: The oncolytic adenovirus Ad5-CD/TKrep (FGR) that expresses a suicide fusion gene to treat prostate cancer [17] is constructed by deletion of E1B55K and E3 and fusion of cytosine deaminase (CD) and herpes simplex virus type-1 thymidine kinase (HSV-1 TK).